Metabolic Profiling of Dividing Cells in Live Rodent Brain by Proton Magnetic Resonance Spectroscopy (1HMRS) and LCModel Analysis by Park,  J. H. et al.
Metabolic Profiling of Dividing Cells in Live Rodent Brain
by Proton Magnetic Resonance Spectroscopy (1HMRS)
and LCModel Analysis
June-Hee Park1, Hedok Lee2, Rany Makaryus2, Mei Yu2, S. David Smith2, Kasim Sayed1, Tian Feng3,
Eric Holland4, Annemie Van der Linden5, Tom G. Bolwig6, Grigori Enikolopov1, Helene Benveniste2,7*
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America, 2Department of Anesthesiology, Stony Brook Medicine, Stony Brook, New
York, United States of America, 3Department of Applied Mathematics and Statistics, Stony Brook University, New York, United States of America, 4Division of Human
Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, 5Department of Biomedical Sciences, Bio-Imaging Laboratory,
University of Antwerp, Belgium, 6Neuropsychiatry Laboratory, Copenhagen University Hospital, Copenhagen, Denmark, 7Department of Radiology, Stony Brook
Medicine, Stony Brook, New York, United States of America
Abstract
Rationale: Dividing cells can be detected in the live brain by positron emission tomography or optical imaging. Here we
apply proton magnetic resonance spectroscopy (1HMRS) and a widely used spectral fitting algorithm to characterize the
effect of increased neurogenesis after electroconvulsive shock in the live rodent brain via spectral signatures representing
mobile lipids resonating at ,1.30 ppm. In addition, we also apply the same 1HMRS methodology to metabolically profile
glioblastomas with actively dividing cells growing in RCAS-PDGF mice.
Methods: 1HMRS metabolic profiles were acquired on a 9.4T MRI instrument in combination with LCModel spectral analysis
of: 1) rat brains before and after ECS or sham treatments and 2) RCAS-PDGF mice with glioblastomas and wild-type controls.
Quantified 1HMRS data were compared to post-mortem histology.
Results: Dividing cells in the rat hippocampus increased ,3-fold after ECS compared to sham treatment. Quantification of
hippocampal metabolites revealed significant decreases in N-acetyl-aspartate but no evidence of an elevated signal at
,1.3 ppm (Lip13a+Lip13b) in the ECS compared to the sham group. In RCAS-PDGF mice a high density (22%) of dividing
cells characterized glioblastomas. Nile Red staining revealed a small fraction (3%) of dying cells with intracellular lipid
droplets in the tumors of RCAS-PDGF mice. Concentrations of NAA were lower, whereas lactate and Lip13a+Lip13b were
found to be significantly higher in glioblastomas of RCAS-PDGF mice, when compared to normal brain tissue in the control
mice.
Conclusions: Metabolic profiling using 1HMRS in combination with LCModel analysis did not reveal correlation between
Lip13a+Lip13b spectral signatures and an increase in neurogenesis in adult rat hippocampus after ECS. However, increases
in Lip13a+Lip13b were evident in glioblastomas suggesting that a higher density of actively dividing cells and/or the
presence of lipid droplets is necessary for LCModel to reveal mobile lipids.
Citation: Park J-H, Lee H, Makaryus R, Yu M, Smith SD, et al. (2014) Metabolic Profiling of Dividing Cells in Live Rodent Brain by Proton Magnetic Resonance
Spectroscopy (1HMRS) and LCModel Analysis. PLoS ONE 9(5): e94755. doi:10.1371/journal.pone.0094755
Editor: Tone Frost Bathen, The Norwegian University of Science and Technology (NTNU), Norway
Received August 29, 2013; Accepted March 19, 2014; Published May 12, 2014
Copyright:  2014 Park et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the National Institute of Aging (R01AG040209), National Institute of Mental Health (R01MH092928), The Ellison
Medical Foundation, and New York State Stem Cell Science (NYSTEM) to GE. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: helene.benveniste@stonybrookmedicine.edu
Introduction
Production of new neurons in the adult brain is associated with
cognitive function, response to therapies, neurodegenerative
diseases, and aging [1–3]. Life-long generation of new neurons
in the hippocampus has now been firmly established for humans
[4]; therefore, it is expected that the ability to track actively
dividing cells in the live brain will impact diagnosis and therapy of
a wide range of disorders of the nervous system. This becomes
possible due to imaging technologies such as positron emission
tomography (PET) in combination with radioactive ligands such as
39-deoxy-39- [18F]fluoro-L-thymidine (18F-FLT) [5,6]. Newly
synthesized DNA of proliferating cells incorporates 18F-FLT much
the same way it incorporates halogenated thymidine analogs 5-
bromo, or 5-chloro-29-deoxyuridine (BrdU and CldU), thus
enabling the use of PET for the detection of dividing cells,
including neuronal progenitors [5,7,8]. Another imaging tech-
nique which has been tested for tracking of neurogenesis in the live
brain is proton magnetic resonance spectroscopy (1HMRS) [9–
11]. For example, a previous 1HMRS study applied singular value
decomposition processing algorithms [10] and reported detection
of neurogenesis in the hippocampus of the live rodent brain after
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repetitive electroconvulsive shock (ECS) treatments via increases in
a lipid-like spectral signature resonating at 1.28 ppm [10,12]. The
origin of the 1.28 ppm signal in NPCs is thought to stem from
mobile fatty acyl chains of triacylglycerides (TG), free fatty acids,
and cholesteryl esters [13] residing in the cytoplasm or near the
cell membranes of neural progenitor cells (NPCs). This possibility
is supported by the association between intracellular lipid bodies
either adjacent to the plasma membrane or within the cytoplasm
and the 1HMRS TG signal in various tissues including brain [13].
It is also supported by the recent finding of high levels of
lipogenesis correlating and being necessary for proliferation of
NPCs in the hippocampus, perhaps reflecting the requirements for
additional lipids to build the structural membranes of the progeny
cells [14].
The study demonstrating an increase in the 1.28 ppm signal via
1HMRS in the live rodent hippocampus following ECS [10] led to
discussions in regards to 1) specificity of the 1.28 ppm signal itself;
for instance, it may be reflecting apoptosis which, while being an
integral part of the neurogenesis cascade, would not necessarily
correlate with division of neural progenitors [11]; 2) the non-
parametric nature of the spectral processing algorithm used and
lack of validation with other more widely used spectral processing
methods [15]; 3) elimination of phase information of the fitted
peaks by the SVD algorithm [16]; and 4) issues pertaining to
assumptions inherent to the singular value decomposition algo-
rithm itself [16–18]. To further investigate the link between the
metabolic profiles of hippocampal cells, neurogenesis, and cell
proliferation, we sought an alternative approach to evaluate the
changes in metabolites in the affected brain.
Over the past decades, a number of spectral metabolite
algorithms have been developed in an effort to estimate metabolite
concentrations accurately and reliably under varying degrees of
spectral quality. These algorithms are based on parameterization
in frequency and time domains [22–24], wavelet transform [25],
and approaches such as principle component analysis [26]. In
particular, we focused on a widely used frequency domain fitting
algorithm, LCModel [22], because it is based on a fully automated
software, calculates spectral signal-to-noise ratio (SNR) and
spectral line-width, is relatively user non-interactive in regards to
fitting parameters and has been widely employed in both animal
and human 1HMRS studies [27–29]. In addition, the algorithm
calculates Cramer-Rao lower bounds as an error estimate [22]. By
using a set of phase modulated frequency peaks measured in vitro as
prior knowledge, LCModel constrains fitting parameters conse-
quently speeding up computation and enables faster estimation of
metabolite concentrations [30,31].
We now apply LCModel as an alternative spectral fitting
algorithm to characterize the 1HMRS metabolic profiles of the live
adult rodent brain before and after repetitive ECS and associate
them with histological evidence of cell division. In addition, we
apply the same methodological approaches to metabolically
characterize glioblastomas (GBMs) [19] growing in genetically-
engineered RCAS-TVA-J12p16/M9Pten mice. In these tumors
dividing cells are abundant and lipid signatures may be amplified
by the presence of intra- or extracellular lipid droplets as has been
reported for other brain tumor models [20,21]. Our results
support the use of LCModel approach for analyzing the metabolic
changes in the adult brain upon stimulation or abnormal cell
division. Raw and processed data obtained in the present study are
available (http://www.hedoklee.com) to all interested investigators
for further analysis and processing using alternate spectral analysis
approaches.
Materials and Methods
The experiments were carried out in strict accordance with the
recommendations in the guide for the Institutional Care and Use
of Laboratory Animals (IACUC) of Brookhaven National Labo-
ratory (IACUC #375), Stony Brook University (IACUC
#227884-4), and Cold Spring Harbor Laboratory (IACUC
#12-09-05-15), who approved the study. All surgical procedures
including electroconvulsive shock were carried out under sodium
pentobarbital anesthesia, and all efforts were made to minimize
suffering. For the ECS experiments, adult female Sprague-Dawley
(SD) rats (Taconic, Inc.) were used. The animals were randomly
assigned to two treatment groups: Group 1 (n = 10) were exposed
to ECS, and Group 2 (n= 10) were exposed to sham treatment. All
animals received a baseline 1HMRS scan and one month later (age
12–14 weeks) were exposed to either ECS or sham treatments for
five consecutive days. The day after the last treatment, the animals
received an i.p. injection of CldU (128 mg/kg, i.p.) to label
dividing stem and progenitor cells and then subjected to a repeat
1HMRS scan -. Twenty-four hours later, the animals received an
overdose of pentobarbital (200 mg/kg) followed by perfusion
fixation with paraformaldehyde and brains were analyzed for cell
division, differentiation, and apoptosis (see details below). For the
GBM mouse model, we used a genetically-engineered RCAS-
TVA-J12p16/M9Pten mouse model [19] in order to compare the
magnitude of lipid resonances at 1.3 ppm with histological
evidence of apoptosis and cell division, as well as the presence of
intra- and extracellular lipid droplets which are present in some
brain tumors when necrosis predominate [20,21]. The RCAS-
TVA-J12p16/M9Pten mouse models are based on the RCAS/t-
va technology, where transgenic mice carrying a viral receptor
produced selectively in nestin-expressing cells are intracranially
injected by a suspension of cultured mammalian cells expressing
genes that can result in malignant cell transformation, such as
PDGF or Kras. Cells that receive the oncogene are those that
express nestin and are assumed to carry stem/progenitor
properties. By carrying out these procedures with mice with
mutations in genes such as p53, ARF, or pTEN, it is possible to
generate tumors that resemble human gliomas. 1HMRS scans
were performed on nine RCAS-TVA-J12p16/M9Pten mice and
five wild-type mice to compare metabolic profiles of normal and
GBM tissue. The mice were injected with BrdU (150 mg/kg, i.p.)
two hours prior to euthanization with an overdose of pentobarbital
and the brains processed for histology (see below).
Electroconvulsive shock (ECS) and sham treatments
ECS was delivered daily for five consecutive days using a pulse
generator (ECT Unit 57800, Ugo Basile, Comeriao, Italy). Sham-
treated controls were handled identically to the ECS-treated rats,
but no electrical shock was administrated. A short-term (30 min)
anesthesia was attained by methohexital sodium (30 mg/kg, i.p.;
Brevital sodium, JHP Pharmaceuticals), a barbiturate anesthetic.
Immediately after the rapid anesthetic induction, a non-paralyzing
dose of succinylcholine chloride (0.5–1 mg/kg, Sigma), a neuro-
muscular blocker, was injected into the femoral muscle 3 min
before ECS, to reduce the otherwise high mortality due to ECS.
Bilateral ECS was applied by clamping both ears via ear clips
dampened in saline to enhance the electric conductance, with
100 Hz of pulse frequency, 0.5 msec of pulse width, 0.5 sec of
shock duration, and 50 mA of current. Three rats died from
respiratory arrest immediately after induction of anesthesia during
the third day of treatment and were excluded from analysis.
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1HMRS, anesthesia and monitoring
Rats. For imaging, the rats were anesthetized with pentobar-
bital (Nembutal, 40 mg/kg, i.p.) and allowed to breathe sponta-
neously during the 1HMRS experiment. Supplemental oxygen
(2 L/min) was supplied via a snout mask. An antisialogue -
glycopyrulate (0.01–0.02 mg/kg, i.p.) mixed with 0.9% NaCl
(4 cc/kg) - was also administered to prevent excessive build-up of
airway secretions and bradycardia during imaging. Physiological
parameters including respiratory rate, oxygen saturation, body
temperature, and heart rate were continuously monitored using
MRI compatible optical monitors (SA Instruments, Inc., Stony
Brook, NY). Body temperature was kept strictly within 36.5–
37.5uC during imaging using an automated heating system (SA
Instruments, Inc., Stony Brook, NY). All 1HMRS acquisitions
were performed on a 9.4T/20 MRI instrument interfaced to a
Bruker Advance console and controlled by Paravision 5.0 software
(Bruker BioSpin, Billerica MA). For signal detection, a custom-
made 3-cm surface radio-frequency coil placed under the rodent’
head was used as a receiver and an 11.2-cm diameter volume coil
(Bruker) was used as a transmitter. Localizer anatomical T2-
weighted images were obtained in three orthogonal planes using a
rapid acquisition with relaxation enhancement (RARE) sequence
(TR=2500, TE= 40 ms, NA=2, RARE factor = 8, number of
slices = 25, in plane resolution = 0.117 mm/pixel, slice-thick-
ness = 0.8 mm, slice gap= 0.1 mm) to assure correct positioning.
First and second order shims were accomplished using MAPSHIM
(Paravision 5.0, Bruker BioSpin, MA). For spectroscopy, two
rectangular single voxel volumes (3.562.262.5 mm3) positioned in
1) the hippocampus that included the subgranular layer of the
dentate gyrus (DG) area, and the 2) somatosensory cortex (Fig. 1)
were excited using a point-resolved spectroscopy (PRESS)
sequence. The following MR parameters were used:
TR=4000 ms, TE= 12 ms; NA=512; spectral width= 8012 Hz,
number of acquired complex points = 4096 yielding a spectral
resolution of 1.96 Hz/pts. Outer volume suppression was carefully
applied using a hyperbolic secant pulse (bandwidth = 10125 Hz) in
order to avoid lipid contamination from the skull. Retro frequency
lock was active during all acquisitions for monitoring of the
unsuppressed water signal within the same voxel volume and to
correct for possible center frequency drift over the 34 min scan
acquisition time. Data were acquired in single-scan mode and each
free induction decay (FID) was therefore saved separately. In this
series, a water unsuppressed scan was also acquired to serve as a
concentration reference.Mice: All mice were anesthetized with 1–
2% isoflurane delivered in a 1:1 Air:O2 mixture and were allowed
to breathe spontaneously. Physiological monitoring was performed
as described for the rats above. Localizer anatomical T2-weighted
images were obtained in three orthogonal planes using a RARE
sequence (TR=2500, TE= 40 ms, NA=2, RARE factor = 8,
number of slices = 23, in plane resolution = 0.10 mm/pixel, slice-
thickness = 0.5 mm, slice gap= 0.1 mm) to assess tumor volume
and to position the voxel for 1HMRS in GBM-like tissue, and in
corresponding anatomical locations in the wild-type control mice.
For 1HMRS a PRESS sequence was used with the following MR
parameters: TR=4000 ms, TE=12 ms, NA=512, spectral
width = 8012 Hz, number of acquired complex points = 2048
yielding a spectral resolution of 3.91 Hz/pts., voxel size
= 26262 mm3. In the 1HMRS acquisitions from the GBM mice,
the spectral voxel was positioned so that it predominantly
contained tumor-like tissue in the mice with larger GBMs but
invariably included non-tumor tissue in mice with smaller GBMs.
Outer volume suppression was carefully applied using a hyperbolic
secant pulse (bandwidth = 10125 Hz) in order to avoid lipid
contamination from the skull.
Spectral data processing
After frequency and phase correction of individual FID signal, a
summed FID signal was constructed using in-house software
written in MATLAB. A summed spectrum was then analyzed by
LCModel [22] using a simulated metabolic profile based on
TE=12 ms PRESS sequence at 9.4T. No filtering was applied to
the summed FID. The following metabolites were included in the
simulated basis set: alanine (Ala), aspartate (Asp), creatine (Cr),
phosphocreatine (PCr), c-aminobutyric acid (GABA), glucose
(Glc), glutamine (Gln), glutamate (Glu), glycerophosphorylcholine
(GPC), phosphorylcholine (PCh), glutathione (GSH), myo-inositol
(myo-Ins), scyllo-inositol (scyllo), lactate (Lac), N-acetylaspartate
(NAA), N-acetylaspartylglutamate (NAAG), phosphoethanolamine
(PE) and taurine (Tau). In addition, simulated spectra of mobile
lipids (fatty acyl proton groups CH2, predominantly saturated
methylene hydrogens; Lip13a, Lip13b and CH3 methyl hydrogen
at Lip09) were included [32]. The LCModel analysis was
performed on each of the TE 12 ms spectra from the chemical
shift range of 0.0–4.0 ppm. The Cramer-Rao lower bounds
(CRLB) were used to eliminate statistically unreliable values.
Quantification of metabolites’ concentration was performed by
calibrating the metabolites signals relative to water unsuppressed
signal, assuming parenchymal water concentration of 36 mM, also
taking into account correcting for differences in receiver gains and
number of acquisitions between suppressed and unsuppressed
scans. A challenge unique to short echo time invivo 1HMRS lies in
the ability to accurately parameterize a broad macro-molecular
baseline [33] [28]. In the present study, we eliminated the need for
parameterizing macro-molecular baseline by including a popula-
tion averaged macro molecular baseline in the basis set. For this
purpose, twelve metabolite-nulled spectra were acquired using the
inversion-recovery PRESS sequence (TR=4000 ms, TE= 12 ms,
inversion time = 950 ms).
The commercially available pentobarbital solution (Nembutal)
produces specific spectral signatures in the brain during anesthesia
due to its high content of propylene glycol (PG) which resonates at
1.13 ppm [34,35]. Thus, in order to accurately identify metabo-
lites from LCModel in the rats anesthetized with pentobarbital, the
spectral resonances resulting from PG in particular also needed to
be incorporated in the basis data set. Phantoms were therefore
prepared containing 5 mM sodium pentobarbital balanced to
pH=7.2 dissolved in standard solvent with 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) as reference for proper phase
correction. The temperature of the phantom was maintained at
37uC and the acquisition parameters were the same as described
for the in vivo experiments except for a TR=10000 msec and a
spectral bandwidth of 7882 Hz. The processed spectra from the
Nembutal phantoms were included in the basis data set according
to protocol [28]. Thus, the final LCModel basis data set used for
analysis of all TE= 12 ms spectra obtained from rats thus
contained brain metabolites, simulated lipids, PG, and macromol-
ecules determined in vivo.
Immunohistochemistry
Neural stem and progenitor cells and other dividing and
apoptotic cells in the sections of the rodent brain using
immunocytochemistry as described elsewhere [36,37] were
quantified from histologically prepared brain sections. After
euthanasia with an overdose of pentobarbital (200 mg/kg, i.p.),
the rodents were transcardially perfused with 200 ml of phosphate
buffered saline (PBS) and 200 ml of 4% paraformaldehyde (PFA)
in PBS. The extracted brains were additionally post-fixed in 4%
PFA in PBS overnight at 4uC and stored in PBS with 0.1% sodium
azide at 4uC until sectioning. The brains were dissected sagittal at
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50 mm thickness by using a vibratome (Vibratome, St. Louis, MO)
and a subset of brain sections from the right hemisphere, collected
at a distance of 600 mm were subsequently used for immunohis-
tochemisty. After rinses with PBS, the sections were denatured in
2 N HCl at 37uC for 1 hr, for detection of CldU incorporated
proliferating stem and progenitor cells or for BrdU. The denatured
sections were neutralized with 0.1 M borate, pH 8.0, twice for 20
minutes. The sections were rinsed with washing solution (PBS with
0.2% Triton X-100) and incubated for blocking and permeabiliza-
tion in PBS with 2% Triton X-100 and 5% goat serum at room
temperature (RT) for 2 hr. After rinses with washing solution, the
sections were incubated, at 4uC overnight, in antibody solution
(PBS with 0.2% Triton X-100 and 3% GS) containing primary
antibodies; rat anti-CldU (Accurate Chemicals, OBT-0030;
1:1,000 dilution), rabbit anti-GFAP (Dako, Z-0034; 1:500
dilution), mouse anti-NeuN (Millipore, MAB-377; 1:800 dilution),
guinea pig anti-BLBP (Frontier Institute, BLBP-BP-Af291-1; 1:400
dilution), rabbit anti-cleaved caspase-3 (Cell Signaling, #9661S,
D175; 1:400 dilution). Two hours after the primary antibody
reaction extension at RT, the sections were rinsed with washing
solution. The sections were incubated in antibody solution, at RT
for 2 hours, with goat secondary antibody and fluorescent dye
conjugates, Alexa fluor (AF, Invitrogen; 1:400 dilution)-405, AF-
488, AF-568, and AF-633, which recognize the corresponding
primary antibodies. After rinses with washing solution, the sections
mounted on gelatin-coated slide glasses were cover-slipped over
fluorescence mounting media (DakoCytomation Fluorescent
Mounting Medium, Carpinteria, CA) for confocal microscopy.
Nile Red staining for lipid droplets and quantification
Brain sections (50 mm thick) were prepared from a) rats exposed
to ECS (n = 7) or sham treatments (n = 8) and b) GBM mice (n = 3)
and wild-type control mice (n = 2). Sections were stained with
Hoechst33342 and/or propidium iodide (2 mg/ml) to visualize and
assess cell nuclei and with the Nile red lipid stain to reveal lipid
droplets [38–40]. Stock Nile red solution (Life Technologies, N-
1142; 1 mg/ml DMSO) was filtered through a 0.22 mm syringe
filter. The sections were incubated at RT for 1 hr in a diluted Nile
red solution (0.1 mg/ml 150 mM NaCl) and then pretreated with
RNase A (25 gm/ml) to avoid staining cytoplasmic RNA during
the blocking and permeabilization steps. After washing with PBS
and mounting, the sections were examined by fluorescence
microscopy. Numbers of normal appearing Nile red+ cells, dying
or apoptotic Nile red+ cells, as well as extracellular Nile red+ lipid
droplets in select sections within the 1HMRS voxel volume were
quantified.
Image capture
Following immunostaining, the brain sections were imaged
using a spinning disk microscope and labeled NPC cells were
counted using optical dissector stereologic technique [41]. All
fluorescence immunostaining images were collected employing a
Perkin-Elmer UltraVIEW VoX high speed spinning disk (Yoko-
gawa CSU-X1) laser confocal microscope and Volocity software.
All representative images were taken by Zeiss LSM710 and
LSM780 and imported into Adobe Photoshop Version 12.0
(Adobe Systems Incorporated, San Jose, CA). Brightness, contrast,
and background were adjusted using the ‘‘brightness and contrast’’
controls.
Quantification of NPCs in adult rat brain
Quantitative analysis of cell populations was performed by
means of design-based (assumption free, unbiased) stereology
[41,42]. Slices were collected using systematic-random sampling.
One brain hemisphere was randomly selected per animal. The
hemisphere was sliced in the sagittal plane in a lateral-to-medial
direction, from the beginning of the lateral ventricle to the center,
thus including the entire DG. The 50 mm slices were collected in
12 parallel sets, each set consisting of 10 slices, each slice 600 mm
apart from the next. For cell quantification in the DG, cells of each
type were counted in every slice, using the 406objective. Adjacent
z-stacks of the entire thickness of the section were collected by
means of confocal microscopy. All of the cells in the section were
counted, excluding those in the uppermost focal plane, and
assigned to their corresponding category (CldU+; CldU+ GFAP+
radial glia-like stem cells; CldU+ GFAP2 amplifying NPCs). The
average number of cells of each category from each slice was
multiplied by 7.2 (average number of slices counted per animal
from one set), and then multiplied by 24 (the number of sets of
slices per animal from two hemispheres) to the value representing
the total number of cells per rat; these numbers are reported.
Quantification of the cell density and populations in GBM
mice
We applied confocal microscopy to quantify cell density and
evaluate cell phenotypes in GBM mice (n = 3) and wild-type
control mice (n = 2). We used a spinning disk microscope (Perkin-
Elmer) with a 60 x objective lens to focus on the areas
corresponding to the 1HMRS voxel position. Stitched confocal
images were obtained for 2 mm (x-axis)61 mm (y-axis)610 mm
(z-axis) areas per section, and cells were analyzed within the voxel
of 1HMRS using at least 2–3 brain sections per mouse. Stitched
images were further cropped to a smaller size of
100 mm6100 mm65 mm for the virtual counting via systemic
and random selection. Cell density and the presence of lipid
droplets were determined using staining with Hoechst33342 and
Nile red respectively. Nile red-positive cells were characterized by
intracellular lipid droplets with a diameter of less than 2 mm in the
cytoplasm, whereas extracellular Nile red-positive lipid droplets
were larger than 2 mm in diameter. Fluorescent signals of
lipophilic Nile red dissolved in DMSO were obtained with an
excitation wavelength of 530 nm and an emission wavelength of
575 nm. The density of BrdU-stained cells and pyknotic cells was
determined by quantifying PI+ cells. Pyknotic cells were defined as
cells, densely stained with PI, characterized by a compact shape
and a condensed nucleus less than 3 mm in diameter. Cell number
and density was determined in all the capture images in several
Figure 1. 1HMRS spectra from the rat hippocampus and cortex analyzed with LCModel. Fig. 1A: The position of the hippocampal voxel is
shown on T2-weighted MRI in the top right corner. The corresponding in vivo 1HMRS spectrum is shown analyzed by LC Model. Fig. 1B: The position
of the cortical voxel is shown on the T2-weighted MRI as well as the in vivo corresponding 1HMRS spectrum. The two spectra shown are of high
quality with spectral resolution necessary to resolve the labeled metabolites. Specifically, the raw unsmoothed spectra are shown (black),the LCModel
fitted spectral output (red solid lines) and the corresponding macromolecular (MM) scan (dotted red lines) measured in the same animal using a
PRESS metabolite nulled inversion-recovery pulse sequence in addition to the residual signals (top spectra). tCr = total creatine; Glx = glutamate +
glutamine; Ins =myo-Inositol; Tau= Taurine; tCho= total choline; NAA=N-acetyl-aspartate; Glu = glutamate; MM=macromolecules; Lac = Lactate;
PG= Propylene glycol.
doi:10.1371/journal.pone.0094755.g001
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views, including 3D opacity and Z plane using Volocity 3D image
analysis software (Version 6.3).
Statistical analysis
All data are presented as mean 6 standard deviation. Statistical
analyses were performed using SAS version 9.2 (SAS Institute Inc.,
NC, USA) and XLSTAT Version 2011 (Addinsoft, NY, USA)
with a p-value ,0.05 as statistically significant. Normality was
examined using the Shapiro-Wilk test. Repeated measures analysis
of variance (ANOVA) was performed to examine if the pre-
selected metabolite concentration change from baseline to pre-op
were different between the ECS or sham groups. Two-sided paired
t-test was performed as post-hoc tests on all pre-selected quantified
metabolites in order to examine how these metabolites changed
between baseline scan and post-treatment scans within each group
respectively, and between normal and tumor tissue in the mice
studies.
Results
Figure 1 shows representative baseline 1HMRS spectra from
the hippocampus (Fig. 1A) and the cortex (Fig. 1B) of a rat (no
line broadening was applied) and the corresponding anatomical
locations of the acquisition voxels in the rat brain. 1HMRS spectra
from the hippocampus were of high quality as evaluated by the full
width at half maximum (FWHM) and the signal-to-noise ratio
(SNR) derived from LCModel which averaged 0.01560.003 and
2564, respectively. The cortical 1HMRS spectra were of inferior
quality compared to those acquired in the hippocampus and five
cortical spectra were discarded from the final analysis due to
highly aberrant baseline LCModel fittings. FWHM and SNR for
the remaining cortical spectra included in the analysis averaged
0.02360.004 and 2363, respectively. Based on an acceptable
range of a given metabolite’ average CRLBs, the concentration of
the following metabolites ([metabolite]) could be quantified in the
hippocampus and cortex: [Cr] (CRLB ,11%), [PCr] (CRLB
,7%), [GABA] (CRLB ,9–16%), [Gln] (CRLB ,7%), [Glu]
(CRLB ,3%), [GSH] (CRLB ,15–30%), [Ins] (CRLB ,7%),
[NAA] (CRLB ,2%), [PE] (CRLB ,12%), [Tau] (CRLB ,4%)
and [GPC+PCh] (CRLB ,10–15%). LCModel via simulation
tracks the 1.28–1.30 ppm component previously found to be
enriched in neural stem cells [10] and is referred to as ‘Lip13a+
Lip13b’. However, analysis of baseline 1HMRS spectra from the
hippocampus demonstrated that the CRLBs of Lip13a+Lip13b
were undetectable (CRLB =999%) in 30% of the animals. For the
cortex, 60% of the baseline CRLBs for Lip13a+lip13b were
undetectable. Therefore, for the rat ECS and sham groups
[Lip13a+Lip13b] are evaluated based on group averaged spectra
of the animals before and after the ECS or sham treatments.
Averaged group spectra for each condition was constructed by
taking an average of the eddy current corrected and water scaled
FID signals of each scan, which thereafter underwent LCModel
analysis for metabolite quantification using the same basis data set
as described previously.
Effect of ECS on metabolites
We first executed a repeated measures ANOVA on pre-selected
metabolites (Glu, Ins, NAA, GPC+PCh and Cr+PCr) in the two
groups to investigate if metabolite concentration changes from
baseline to post-treatments scans were different via significance test
for ‘group by time effect’. A two-tailed paired t-test was used to
determine whether the mean metabolite concentrations were
significantly different between the baseline and the post-treatment
states. Hippocampus: In the ECS group, only the mean [NAA]
difference was significantly different from zero. Specifically, the
[NAA] significantly decreased from 5.7 mM to 5.4 mM after ECS
exposure (p-value = 0.001) (Table 1). In the sham group no
differences were found. Given that the concentration estimations
of [Lip13a+Lip13b] and [Lip09] were very low and in many
animals undetectable (as evidenced by the CRLBs), baseline and
post-ECS spectra were summed and averaged to increase overall
SNR. In this analysis, [Lip13a+Lip13b] before and after ECS was
2.8 mM (CRLB 14%) and 2.0 mM (CRLB 27%), respectively.
Figure 2 shows the averaged pre- and post-ECS spectra from the
hippocampus and also magnifies the spectral range from 1.5–
1.0 ppm between the two conditions. It is clear from Fig. 2 that
the NAA peak is lower after ECS when compared to baseline.
However, there is no apparent difference in the spectral 1.5-
1.0 ppm between the two groups of animals suggesting subtle or
no changes in mobile lipids (Fig. 2). In the sham group [Lip13a+
Lip13b] was 2.2 mM (CRLB 14%) and 0 mM (CRLB 999%)
before and after sham treatment, respectively. Cortex: Several
cortical spectra were discarded due to poor spectral line width
and/or SNR, and spectra were available for 5 rats from ECS
group 1 and 7 rats from the sham group 2. Significant group by
time effect was found for [NAA] (p-value = 0.0075). Similar to the
hippocampus, [NAA] significantly decreased after ECS treatment
compared to baseline, while the concentrations of remaining
metabolites were unchanged (results not shown).
ECS increases cell proliferation in rat hippocampus
To examine the effects of ECS on cell proliferation in the adult
hippocampus, we labeled newly synthesized DNA by injecting
thymidine analog CldU. The total number of CldU+ cells in the
DG increased significantly in rats exposed to repetitive ECS
compared to the sham-operated rats (Fig. 3B–D) (ECS CldU+
cells = 1677162274 versus sham CldU+ cells = 58236577,
p = 0.0003). The majority of CldU-labeled cells in both sham
and ECS groups resided in the subgranular zone of the DG and
corresponded to the transit amplifying rapidly dividing NPC
(Fig. 3B–C). We also analyzed the brain sections for apoptotic
cells, revealed by antibodies to activated caspase 3; there was no
significant difference between the sham and the ECS groups
(Fig. 3C, D). Finally we analyzed the brain sections for the
presence of lipid droplets by Nile red staining; however, lipid
droplets were absent both in the ECS- and sham-treated rats.
RCAS-TVA-J12p16/M9Pten mice versus wild-type mice
We next examined the presence of the lipid [Lip13a+Lip13b]
signals in the RCAS-TVA-J12p16/M9Pten mouse model of GBM
[19,43]. The T2-weighted MRIs revealed that the tumor size in
the RCAS-TVA-J12p16/M9Pten mice varied greatly. Four mice
had large tumors located in the forebrain which often extended
from the olfactory bulb to the hippocampus and involved both
hemispheres and the other 4 had smaller frontal positioned tumors
(Fig. 4). The T2-weighted MRIs acquired from the mice with
larger tumors revealed circular areas characterized by voxels with
mixed low- and high signal intensities and the large GBMs
compressed the lateral ventricles (Fig. 4 A–D). 1HMRS spectra
from the RCAS-TVA-J12p16/M9Pten mice were of varying
quality due to magnetic field inhomogeneity, tumor size and
1HMRS voxel location. The average FWHM and SNR were
0.06660.025 and 964, respectively. In control mice the 1HMRS
spectra were of better quality as signified by an average FWHM
and SNR of 0.03660.007 and 961, respectively. Figure 5 shows
the 1HMRS voxel location on a T2-weighted MRI and the
corresponding 1HMRS spectra from a control wild type mouse
(Fig. 5A, B) and a RCAS-TVA-J12p16/M9Pten mouse with
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large GBM (Fig. 5C, D). The 1HMRS spectrum from the tumor
is dominated by the large, broad lipid peak at 1.3 ppm and a
smaller one at 0.9 ppm. The average CRLBs of [Lip13a+13b] was
,20% which justified quantitative analysis. Quantitative analysis
of [Lac], [NAA], [Lip13a+13b] and [Lip09] from normal and
RCAS-TVA-J12p16/M9Pten mice with large tumors (N= 4)
demonstrated that [Lac], [Lip13a+13b] and [Lip09] were
significantly elevated while [NAA] was reduced in tumor tissue
compared to normal brain (Table 2). Figure 6 shows histology
from one of the RCAS-TVA-J12p16/M9Pten tumors and
demonstrates that in this particular tumor small islets of apoptotic
cells are present; however, the majority of cells correspond to
Figure 2. Summed and averaged 1HMRS hippocampal spectra before and after ECS. Fig. 2A: The summed and averaged baseline spectra
acquired in the hippocampus from all the ECS rats (n = 7) are shown in red and the summed post-ECS spectra from the same rats are shown in blue.
Note that the NAA peak is smaller in the summed post-ECS spectrum when compared to baseline summed and averaged spectra. Fig. 2B:
Enlargement of the spectral profiles in the spectral range of 1.5 ppm–1.0 ppm from the summed baseline and post-ECS spectra are shown
demonstrating that among the visible peaks, only propylene glycol appears to be different between the two conditions. NAA = N-acetyl-aspartate.
doi:10.1371/journal.pone.0094755.g002
Table 1. Hippocampal metabolite concentrations before and after ECS or sham treatment.
Metabolite ECS Group (n =7) Sham Group (n =8)
BaselinemM Post-ECSmM Baseline mM Post-Sham mM
Glutamate 6.3760.52 6.3260.50 5.8560.50 5.9060.83
Myo-Inositol 4.1860.39 4.3060.35 3.9860.50 4.3860.65
N-Acetyl-Aspartate 5.7660.23 5.4260.16* 5.5860.41 5.6660.68
Glycerophosphorylcholine + Phosphorylcholine 1.8060.34 1.6860.41 1.6360.37 1.8160.85
Creatine + Phosphocreatine 5.5760.07 5.5360.16 5.4360.16 5.4460.49
For the ECS as well as the sham group a two-sided paired t-test was performed to determine whether the mean metabolite concentration difference from baseline to
post-treatment was significantly different from zero. Data are presented as mean 6 standard deviation (SD). (*p,0.001).
doi:10.1371/journal.pone.0094755.t001
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dividing BrdU+ cells. Figure 7 shows examples of Nile red
staining and the quantitative data from three of the RCAS-TVA-
J12p16/M9Pten mice with tumors. The low magnification images
from one of the mice with a smaller tumor demonstrates high
density of dividing BrdU+ cells; furthermore, counter-staining of
nuclei with PI clearly shows high cell density in the tumor
compared to the normal surrounding tissue (Fig. 7A). The higher
magnification images of the tumor-enriched area reveal increased
cell proliferation activity, with a large number of BrdU+ cells
distributed throughout the tumor (although some areas exhibited
more dividing cells than others) (Fig. 7B, upper panel). In the very
center of the tumor, pyknotic degenerated cells (characterized by
their smaller and more compact nuclei) were evident (Fig. 7B,
lower panel). The result of the Nile red staining is shown in
Fig. 7C; where Nile red+ lipid droplets are seen as densely stained
structures. Specifically, Nile red+ cells with intracellular lipid
droplets and extracellular Nile red+ lipid droplets are observed
within the tumor. The periphery of the tumor is characterized by a
smaller number of Nile red+ lipid droplets when compared to the
center of the tumor where necrotic cells are present (Fig. 7C).
Quantification of cell populations on the brain sections from GBM
(N=3) and WT (N=2) mice (within the voxel volume used for
1HMRS) revealed the following: a) cell density (as determined by
Hoechst33342 staining) was ,4-fold higher in the tumor
compared to tumor-free tissue and/or control mice (Fig. 7D); b)
within the tumor, ,20% of the cells were BrdU+ and there were
nearly 300-fold more dividing cells within the tumor when
compared to non-tumor tissue (Fig. 7E); c) 4-fold more pyknotic
cells were observed within the tumor when compared to non-
tumor tissue (Fig. 7F); and d) there were 10-fold more cells with
intra-cellular lipid droplets within the tumor when compared to
cells in non-tumor tissue or wild-type control mice (Fig. 7G).
Figure 3. ECS does not induce neuronal loss. Fig. 3A: Representative images of the DG of sham and ECS-treated rats immunostained with neural
marker NeuN. Fig. 3B: Representative images from sham and ECS-treated rats stained with anti-NeuN, anti-activated caspase 3, propidium iodide, and
Hoechst33342. Arrows show activated caspase 3-positive apoptotic cells. Apoptotic cells stained for activated caspase 3-positive are characterized by
compacted and shrunken nucleus as accessed by Hoechst33342 and PI. Fig. 3C: Histogram illustrating that there is no difference in the number of
activated caspase 3-positive cells in the DG from sham (n= 8) and ECS (n = 7) rats. Fig. 3D: Distribution of activated caspase 3-labeled cells in the DG,
illustrating that the hilus and inner molecular layer contains the majority of apoptotic cells. The SZG had very few apoptotic cells and the granular cell
layer (GCL) did not show cells positive or activated caspase 3. Scale bars: Fig. 3A, 100 mm; Fig. 3B, 10 mm.
doi:10.1371/journal.pone.0094755.g003
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Discussion
In the present study, metabolic changes in the live rodent brain
before and after repetitive ECS were assessed using 1HMRS
acquired at 9.4T in combination with LCModel spectral fitting,
and compared to quantitative immunohistological analysis of stem
and progenitor cell proliferation in the DG of the hippocampus.
We demonstrated that the total number of CldU+ cells (the
majority of these representing amplifying NPCs) in the subgra-
nular zone (SGZ) of the DG increased significantly (,3-fold) in
rats exposed to repetitive ECS compared to the sham group. The
increase in hippocampal neurogenesis induced by ECS was
associated with a 6% decrease in [NAA], however, we were not
able to detect any other significant metabolic changes. Specifically,
we did not document an increase in mobile lipids resonating at
,1.28–1.30 ppm which has previously been shown to be enriched
in neuronal stem cells in vitro and to increase in the live rodent
brain after ECS when spectral processing was executed with
singular value decomposition analysis to compute frequency
spectra from time-domain MRS data [10]. We chose to do
spectral processing with LCModel [22], because it has been
extensively studied for its accuracy and reliability in both animal
and clinical studies [27–29]. In addition, an experimentally
acquired macro-molecular baseline which can influence the
Figure 4. Glioblastoma size varies in the RCAS-TVA-J12p16/M9Pten mouse model. T2-weighted horizontal MRIs at the level of the lateral
ventricles from four RCAS-TVA-J12p16/M9Pten mice with large glioblastomas (GBMs) (Fig. 4, A–D) and two RCAS-TVA-J12p16/M9Pten mice who
developed smaller frontal GBMs) (Fig. 4, E–F) are shown. For each MRI image, a corresponding color-coded icon is shown to the right illustrating the
GBM (black) in relation to ventricles (white) and the rest of the brain (red). As can be seen, the larger GBMs are compressing the lateral ventricles and
incorporate both hemispheres. The T2-weighted MRIs of the mice with large GBMs demonstrate that the tumor tissue contain scattered areas
associated with lower signal intensity and further that tissue at the edge of the tumor often is associated with brighter signal intensity. The smaller
GBMs in Fig. 4E and F are located in frontal cortical areas and also contain tissue with mixed low and bright signal intensities. Scale bar = 2 mm.
doi:10.1371/journal.pone.0094755.g004
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accuracy of the fit at ,1.30 ppm was incorporated in the
LCModel basis set. However, with these specific spectral
processing conditions, we were not able to detect increases in
the hippocampal Lip13a+Lip13b spectral signature in rats exposed
to ECS when compared to baseline values. It is also noteworthy
that we observed a decrease in [Lip13a+Lip13b] in sham treated
rats when compared to baseline levels. Clearly, if baseline levels
had not been obtained for each condition, a comparison of post-
ECS and post-sham spectra would suggest that [Lip13a+Lip13b]
increased after ECS. These results emphasize the importance of
Figure 5. 1HMRS spectra from glioblastoma are characterized by increased lipid signals. The 1HMRS voxel location on a T2-weighted MRI
and the corresponding 1HMRS spectra from a control wild type mouse (Fig. 5 A, B) and a RCAS-TVA-J12p16/M9Pten mouse with large a glioblastoma
(GBM) (Fig. 5 C, D) are shown. The 1HMRS spectrum from the GBM is dominated by the large and broad lipid peaks at 1.3 ppm and 0.9 ppm. The raw
unsmoothed spectra are shown (black), the LCModel fitted spectral output (red solid lines). tCr = total creatine; Glx = glutamate + glutamine;
Ins =myo-Inositol; Tau= Taurine; tCho= total choline; NAA=N-acetyl-aspartate; Glu =glutamate; MM=macromolecules; Lac = Lactate; GABA= -
gamma-aminobutyric acid.
doi:10.1371/journal.pone.0094755.g005
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sham controls, but are difficult to interpret given the small sample
size and the overall low [Lip13a+Lip13b] signal. It is possible that
the overall quality (SNR and FWHM) of the hippocampal spectra
acquired in the present study were inadequate for LCModel to
reliably detect subtle changes in mobile lipids present in very low
concentration ranges. Future studies focused on increasing spectral
SNR using better hardware (e.g. cryo-probes, higher magnetic field
strengths), more scan repetitions, and/or ultra-short TE pulse
sequences will be able to address this issue. Alternatively
AMARES [23], a prior knowledge-based algorithm using time
domain signals, is also suitable for 1HMRS analysis and could be
applied in future analysis. LCMODEL and AMARES have been
reported to yield comparable performance as long as the
underlying basis set is the same [44].
Ideally, the new 1HMRS data acquired before and after ECS
analyzed with LCModel software should be compared with the
SVD algorithm [10] to fully validate the sensitivity of LCModel in
regards to detection of neurogenesis in the adult rat brain. In the
absence of direct comparison of the LCModel derived data in this
work with that of the previously used SVD algorithm, our study as
such can neither support nor negate the previous SVD data
obtained in rats exposed to ECS [10]. Our raw unprocessed
spectra and LCModel processed data are available to all interested
investigators for further analysis and processing using alternate
spectral analysis approaches.
The quantitative 1HMRS analysis revealed that [NAA] was
reduced by 6% in both the hippocampus (Table 1 and 2) and
cortex after ECS when compared to baseline values. With the
assumption that [NAA] reflects neuronal density, a decrease in
[NAA] could indicate that the ECS procedure itself lead to some
neuronal loss since there were no [NAA] changes observed in the
sham controls. However, we did not observe an increased number
of apoptotic cells in the hippocampus after ECS when compared
to sham (Fig. 3). In human studies, investigators have reported
that hippocampal [NAA] is unchanged after ECT [45,46] and
others have reported an increase in [NAA] in ECT responders
Figure 6. Immunohistochemistry of glioblastoma with elevated mobile lipid signal. To assess tumor growth, the RCAS-TVA-J12p16/
M9Pten mice were injected with BrdU (150 mg/kg, i.p.) 2 hr before euthanasia. Fig. 6A: T2-weighted MRI of a RCAS-TVA-J12p16/M9Pten mouse who
developed a small glioblastoma GBM in the left hemisphere. The region of the cerebral cortex (white inset) containing GBM and normal tissue was
tracked and matched with histology (Fig. 6B–E). Fig. 6B: Immunostaining for BrdU and activated caspase 3, demonstrating that the GBM is filled with
dividing cells mixed with islets of apoptotic cells. Fig. 6C–E: Higher magnification views of the inset in Fig. 6B illustrating the high density of dividing
BrdU-positive cells intermingled with scattered apoptotic cells. (Fig. 6F–H) The GBM tissue immunostained for anti-BrdU and GFAP, a marker of neural
stem cells and mature astrocytes. The images presented in Fig. 6B–H are single projection views based on 20-mm serial optical z-stacks. Scale bars:
Fig. 6B, 1 mm; Fig. 6C–E, 10 mm; Fig. 6F–H, 100 mm.
doi:10.1371/journal.pone.0094755.g006
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Figure 7. BrdU+ dividing cells and Nile red+ pyknotic cells in glioblastomas. Fig. 7A: Low magnification images of an RCAS-TVA-J12p16/
M9Pten mouse with a glioblastoma (GBM), characterized by high cell density as demonstrated by counter-staining nuclei using PI. BrdU+ dividing
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[47]. In animal studies, metabolomic profiling with 1HMRS after
ECS quantitative results have been reported in terms of metabolite
ratios relative to total creatinine or NAA. For example, Sartorius et
al., reported that the choline/NAA ratio increased after ECS
treatment [48]. For comparison, in our study the choline/NAA
ratio before and after ECS was unchanged. Biederman et al., have
reported hippocampal changes in glutamate and choline in an
animal model of treatment resistant depression (congenital learned
helpless rats) after ECS, which also could not be confirmed in our
study [49]. The differences in metabolic profiles reported
previously and in the present study could be attributed to
differences in animal strains, method of ECS and/or anesthesia
regimen.
We also executed a separate series of 1HMRS experiments on
mice with brain tumors infiltrated by actively dividing cells. Under
these conditions metabolomic profiling with LCModel revealed an
elevated, broad peak in the spectral range of 1.30 ppm as has
previously been reported in other models of brain tumors by other
investigators using LCModel analysis as well as other processing
approaches [50–52]. High concentrations of lactate in brain
tumors have also been reported and because the lactate –CH3
signal co-resonates with the methylene signals from mobile lipids
at 1.3 ppm, it is often difficult to separate the two molecules using
in vivo 1HMRS [20,53]. In the RCAS-PDGF mice with large
GBMs (n= 4) the lactate concentration averaged 8.3 mM which is
in range with values reported in brain GBMs [54]. Additional
spectral editing sequences such as two-dimensional MR spectros-
copy [20,53] are often used to make a conclusive assignment of
lactate and lipid signals.
Metabolic profiling of human brain tumors using 1HMRS have
revealed decreased levels of NAA, increased levels of choline,
lactate, and mobile lipids [55–57]. Similarly, in preclinical studies,
the amount of NAA was found to be lower in certain glioma
models and the lipid 1.3 ppm peak significantly higher in
particular in C6 glioma models [52]. The elevated lipid levels in
brain tumors have been associated with various signatures
including necrosis, membrane breakdown, cellular proliferation
and/or apoptotic cells [13,58]. Mobile lipids in tumors have also
been associated with intracellular lipid bodies comprising mainly
triglycerides [13].
In certain types of brain tumors including GBMs intra- and
extra-cellular lipid droplets are present and have been associated
with a higher than normal lipid signature by 1HMRS [20]. For
example, in a recent study a C6 cell glioma rat model was used to
characterize how metabolic signatures (via 1HMRS) of the tumor
tracked over time compare with histological evidence of necrosis
and lipid droplets [20]. In the early phases of tumor growth (7–14
days after C6 cell implantation) no lipid droplets and/or necrosis
was present in the small-sized tumors and there was also no lipid
signal detected by 1HMRS [20]. However, as the C6 GBM grows
larger, necrosis and lipid droplets (0.2–2 mm) start to predominate
and the area of necrosis is positively correlated with the
corresponding magnitude of the lipid signature [20]. In the GBMs
of RCAS-PDGF mice used in the present study, we also observed
that a small fraction of dead or dying cells within the tumor
contained lipid droplets (dying cells were present mostly in the very
center of the tumor). Larger sized lipid droplets were also present
in the extracellular space, again mostly in the very center of the
tumor. Quantification of different cell types (i.e., BrdU+ prolifer-
ating cells, normal appearing non-dividing cells, and Nile red+
cells) within the area of the 1HMRS voxel used for the acquisition
revealed cells (3%) that contained lipid droplets and a large
amount of BrdU+ cells (20%). In other words, there are many
more dividing cells than degenerating necrotic and apoptotic cells
with lipid droplets in the tumor-abundant area and the mobile
lipid signature may be derived from both of these entities.
We also observed decreased levels of NAA and increased levels
of lactate and lipids. However, we could not confirm increased
levels of choline as has been observed in other GBM animal
models [51]. We also correlated the metabolic profiles of the
cells are clearly evident within the tumor. Fig. 7B: Higher magnification images of the tumor, demonstrating high proliferative activity; BrdU+ dividing
cells are distributed throughout the tumor (upper panel). Pyknotic cells are present in the very center of the tumor (lower panel). Pyknotic cells are
characterized by PI staining as having smaller and more compact nuclei (lower panel). Scale bars, 10 mm. Fig. 7C: Higher magnification images of the
tumor showing Nile red+ lipid droplets (visualized as small densely stained green structures). Nile red+ cells with intracellular lipid droplets (white
arrows) and extracellular Nile red+ lipid droplets (red arrowheads) are clearly visible. The perimeter of the tumor (upper panel) is characterized by a
smaller number of Nile red+ lipid droplets as compared to the center of the tumor (lower pane) suggesting that the latter contains more necrotic
cells. Hoechst33342 (H), a nuclear counter-staining dye. Scale bars, 10 mm; please note that in Fig. 7B–C representative images of cell density and
populations are acquired at 0.5 mm of z stack depth. Fig. 7D: Cell density was determined by Hoechst33342 (H) staining. The tumor-enriched area is
characterized by significantly higher cell density when compared to that of control mice or tumor-free tissue. Fig. 7E: Dividing cells were determined
by BrdU immunohistochemisty and non-dividing cells by the nuclear counter-staining with PI. About 22% of cells were BrdU+ dividing cells in the
tumor-enriched areas; and when correcting for cell density there were 40-fold more BrdU+ cells in the tumor when compared to non-tumor tissue.
Fig. 7F: Pyknotic cells with small and compact nuclei are observed in the very center of the tumor. Approximately 5% of cells in the tumor-enriched
area were pyknotic (20-fold more dead cells were observed in the tumor when compared to normal tissue). Fig. 7G: When accounting for cell density
there were at least10-fold more lipid-containing cells in the tumor when comparing to non-tumor tissue.
doi:10.1371/journal.pone.0094755.g007
Table 2. Metabolite profile of WT and RCAS-TVA-J12p16/M9Pten with large glioblastomas.




Lip13a + Lip13b 1.2361.44 24.75621.75*
Lip09 0.6360.64 5.4463.27*
A two-sided independent t-test was performed to determine whether the mean metabolite concentration of WT and RCAS-TVA-J12p16/M9Pten mice with large tumors
were significantly different. Data are presented as mean 6 standard deviation (SD). GPC=Glycerophosphocholine; PCh = Phosphocholine. *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0094755.t002
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GMBs with post-mortem evidence of cell proliferation (via BrdU)
and apoptosis (via activated caspase-3 staining). The increased
lipid peak was evident in both large and smaller GBMs and may
be associated with the greatly increased cell division and/or a
small fraction of lipid droplets. Noteworthy GBM cells carry
numerous features of NPCs [59–61] and increased lipid signals
may reflect high levels lipogenesis [14] in these rapidly dividing
cells; however, it is also conceivable that oligodendrocytes in the
tumor may contribute to the lipid signal.
In conclusion, our data show that increases in mobile lipids after
ECS could not be confirmed in rats with evidence of a 3-fold
increase in NPCs using in vivo 1HMRS and LCModel analysis.
However, increases in the concentration of lipid signatures at
1.3 ppm and 0.9 ppm were evident in RCAS-PDGF mice with
GBMs when compared to normal control mice.
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